Right-sided Infective Endocarditis

• FDA approval · 2023-09-19
  FDA Approved: DAPTOMYCIN — Supplemental Application (Sagent Pharmaceuticals)

  The FDA approved a supplemental application for daptomycin filed by Sagent Pharmaceuticals (ANDA 207104), resulting in an approved regulator…

• FDA approval · 2019-08-22
  FDA Approved: DAPTOMYCIN — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s generic daptomycin under an Original Application. The approval covers the same indications as …